Influenza virus vaccine, h5n1 Side Effects
Medically reviewed by Drugs.com. Last updated on Oct 20, 2022.
Applies to influenza virus vaccine, h5n1: intramuscular suspension.
General
The most common adverse events were injection site pain, muscle aches, and irritability.[Ref]
Local
Very common (10% or more): Injection site pain (83%), injection site erythema (33.7%), injection site swelling (28.6%)
Common (1% to 10%): Injection site pruritus, injection site warmth
Uncommon (0.1% to 1%): Injection site reaction[Ref]
Musculoskeletal
Very common (10% or more): Muscle aches (45%), arthralgia (25%), joint pain (17.1%)
Rare (less than 0.1%): Polymyalgia rheumatic, rheumatoid arthritis[Ref]
Psychiatric
Very common (10% or more): Irritability/fussiness (82%)[Ref]
Nervous system
Very common (10% or more): Headache (35%), drowsiness (37.8%)
Common (1% to 10%): Dizziness
Rare (less than 0.1%): Convulsion, cerebrovascular accident, cranial nerve IV palsy, facial palsy, radiculitis, febrile convulsion[Ref]
Other
Very common (10% or more): Fatigue (34%), fever (22.4%), shivering (17%)[Ref]
Respiratory
Rare (less than 0.1%): Pulmonary embolism, rheumatoid lung[Ref]
Metabolic
Very common (10% or more): Loss of appetite (29.1%)[Ref]
Gastrointestinal
Very common (10% or more): Gastrointestinal reaction (nausea, vomiting, diarrhea, and/or abdominal pain) (17.2%)
Common (1% to 10%): Gastroenteritis
Rare (less than 0.1%): Celiac disease, Crohn's disease[Ref]
Dermatologic
Very common (10% or more): Sweating (11%)
Uncommon (0.1% to 1%): Rash
Rare (less than 0.1%): Psoriasis, erythema nodosum, alopecia[Ref]
Ocular
Common (1% to 10%): Eye infections
Rare (less than 0.1%): Corneal transplant rejection[Ref]
Hepatic
Rare (less than 0.1%): Autoimmune hepatitis[Ref]
Cardiovascular
Rare (less than 0.1%): Temporal arteritis[Ref]
Oncologic
Rare (less than 0.1%): Thyroid cancer[Ref]
More about influenza virus vaccine, h5n1
- Check interactions
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: viral vaccines
Patient resources
Other brands
Related treatment guides
References
1. "Product Information. Influenza Virus Vaccine, H5N1, Inactivated (influenza virus vaccine, H5N1, inactivated)." GlaxoSmithKline (2022):
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.